Literature DB >> 21955238

Simian virus 40 transformation, malignant mesothelioma and brain tumors.

Fang Qi1, Michele Carbone, Haining Yang, Giovanni Gaudino.   

Abstract

Simian virus 40 (SV40) is a DNA virus isolated in 1960 from contaminated polio vaccines, that induces mesotheliomas, lymphomas, brain and bone tumors, and sarcomas, including osteosarcomas, in hamsters. These same tumor types have been found to contain SV40 DNA and proteins in humans. Mesotheliomas and brain tumors are the two tumor types that have been most consistently associated with SV40, and the range of positivity has varied about from 6 to 60%, although a few reported 100% of positivity and a few reported 0%. It appears unlikely that SV40 infection alone is sufficient to cause human malignancy, as we did not observe an epidemic of cancers following the administration of SV40-contaminated vaccines. However, it seems possible that SV40 may act as a cofactor in the pathogenesis of some tumors. In vitro and animal experiments showing cocarcinogenicity between SV40 and asbestos support this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21955238      PMCID: PMC3241931          DOI: 10.1586/ers.11.51

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  131 in total

1.  Small tumor virus genomes are integrated near nuclear matrix attachment regions in transformed cells.

Authors:  K A Shera; C A Shera; J K McDougall
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters.

Authors:  Barbara Kroczynska; Rochelle Cutrone; Maurizio Bocchetta; Haining Yang; Amira G Elmishad; Pamela Vacek; Maria Ramos-Nino; Brooke T Mossman; Harvey I Pass; Michele Carbone
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

3.  Association of SV40 with human tumors.

Authors:  George Klein; Amy Powers; Carlo Croce
Journal:  Oncogene       Date:  2002-02-14       Impact factor: 9.867

4.  Simian virus 40-like DNA sequences in human pleural mesothelioma.

Authors:  M Carbone; H I Pass; P Rizzo; M Marinetti; M Di Muzio; D J Mew; A S Levine; A Procopio
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

5.  Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters.

Authors:  Niraj C Patel; Steven J Halvorson; Vojtech Sroller; Amy S Arrington; Connie Wong; E O'Brian Smith; Regis A Vilchez; Janet S Butel
Journal:  Virology       Date:  2009-01-31       Impact factor: 3.616

Review 6.  Cell and molecular biology of simian virus 40: implications for human infections and disease.

Authors:  J S Butel; J A Lednicky
Journal:  J Natl Cancer Inst       Date:  1999-01-20       Impact factor: 13.506

7.  Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma.

Authors:  Andrea Sartore-Bianchi; Fabio Gasparri; Arturo Galvani; Linda Nici; James W Darnowski; Dario Barbone; Dean A Fennell; Giovanni Gaudino; Camillo Porta; Luciano Mutti
Journal:  Clin Cancer Res       Date:  2007-10-01       Impact factor: 12.531

8.  SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells.

Authors:  Jodie R Pietruska; Agnes B Kane
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

9.  SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice.

Authors:  R D Palmiter; H Y Chen; A Messing; R L Brinster
Journal:  Nature       Date:  1985 Aug 1-7       Impact factor: 49.962

10.  Molecular identification of SV40 infection in human subjects and possible association with kidney disease.

Authors:  Rui-Mei Li; Mary H Branton; Somsak Tanawattanacharoen; Ronald A Falk; J Charles Jennette; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

View more
  16 in total

1.  CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma.

Authors:  Zeyana Rivera; Soldano Ferrone; Xinhui Wang; Sandro Jube; Haining Yang; Harvey I Pass; Shreya Kanodia; Giovanni Gaudino; Michele Carbone
Journal:  Clin Cancer Res       Date:  2012-08-14       Impact factor: 12.531

2.  Survey for human polyomaviruses in cancer.

Authors:  Tuna Toptan; Samuel A Yousem; Jonhan Ho; Yuki Matsushima; Laura P Stabile; Maria-Teresa Fernández-Figueras; Rohit Bhargava; Akihide Ryo; Patrick S Moore; Yuan Chang
Journal:  JCI Insight       Date:  2016-02-25

Review 3.  Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator.

Authors:  Sarah Beltrami; Richard Kim; Jennifer Gordon
Journal:  Anticancer Res       Date:  2013-01       Impact factor: 2.480

Review 4.  The function, mechanisms, and role of the genes PTEN and TP53 and the effects of asbestos in the development of malignant mesothelioma: a review focused on the genes' molecular mechanisms.

Authors:  Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  Tumour Biol       Date:  2013-10-01

Review 5.  Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysis.

Authors:  Bettina Klug; James S Robertson; Richard C Condit; Stephen J Seligman; Marian P Laderoute; Rebecca Sheets; Anna-Lise Williamson; Marc Gurwith; Sonali Kochhar; Louisa Chapman; Baevin Carbery; Lisa M Mac; Robert T Chen
Journal:  Vaccine       Date:  2016-06-15       Impact factor: 3.641

Review 6.  Human BK Polyomavirus-The Potential for Head and Neck Malignancy and Disease.

Authors:  Raquel Burger-Calderon; Jennifer Webster-Cyriaque
Journal:  Cancers (Basel)       Date:  2015-07-08       Impact factor: 6.639

7.  Parakeratotic-like cells in effusions - A clue to diagnosis of malignant mesothelioma.

Authors:  Ling Gao; Ward Reeves; Richard M Demay
Journal:  Cytojournal       Date:  2012-07-28       Impact factor: 2.091

8.  NLRP1 polymorphisms in patients with asbestos-associated mesothelioma.

Authors:  Martina Girardelli; Iva Maestri; Rosa R Rinaldi; Mauro Tognon; Renzo Boldorini; Massimo Bovenzi; Sergio Crovella; Manola Comar
Journal:  Infect Agent Cancer       Date:  2012-10-02       Impact factor: 2.965

Review 9.  Matrix and backstage: cellular substrates for viral vaccines.

Authors:  Ingo Jordan; Volker Sandig
Journal:  Viruses       Date:  2014-04-11       Impact factor: 5.048

10.  Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis.

Authors:  Roberta Rizzo; Silvia Pietrobon; Elisa Mazzoni; Daria Bortolotti; Fernanda Martini; Massimiliano Castellazzi; Ilaria Casetta; Enrico Fainardi; Dario Di Luca; Enrico Granieri; Mauro Tognon
Journal:  J Transl Med       Date:  2016-07-22       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.